Alterations in this pathway in breast cancers are often caused by mutations or aberrant expression of numerous genes, including: HER2, BRCA1, BRCA2, EGFR1, ERα, PTEN, PI3K, TP53, RB [37, 38]. Here, ERBB2 is linked to breast carcinoma.